The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-19 of 19 articles
Five-year outcomes of mild paravalvular regurgitation after transcatheter aortic valve implantation
May 15, 2022 | 10.4244/EIJ-D-21-00784
Reply: The time has come to use attitudinally appropriate terminology when describing cardiac anatomy
April 22, 2022 | 10.4244/EIJ-D-21-01077R
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian A,
Praz F,
Milojevic M,
Baldus S,
Bauersachs J,
Capodanno D,
Conradi L,
De Bonis M,
De Paulis R,
Delgado V,
Freemantle N,
Haugaa K,
Jeppsson A,
Jüni P,
Pierard L,
Prendergast B,
Sádaba J,
Tribouilloy C,
Wojakowski W,
Beyersdorf F
February 4, 2022 | 10.4244/EIJ-E-21-00009
Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition
Gragnano F,
Spirito A,
Corpataux N,
Vaisnora L,
Galea R,
Gargiulo G,
Siontis G,
Praz F,
Lanz J,
Billinger M,
Hunziker L,
Stortecky S,
Pilgrim T,
Bär S,
Ueki Y,
Capodanno D,
Urban P,
Pocock S,
Mehran R,
Heg D,
Windecker S,
Räber L,
Valgimigli M
December 3, 2021 | 10.4244/EIJ-D-21-00181
Transcatheter treatment for tricuspid valve disease
Praz F,
Muraru D,
Kreidel F,
Lurz P,
Hahn R,
Delgado V,
Senni M,
von Bardeleben R,
Nickenig G,
Hausleiter J,
Mangieri A,
Zamorano J,
Prendergast B,
Maisano F
November 19, 2021 | 10.4244/EIJ-D-21-00695
Outcomes of transcatheter tricuspid valve intervention by right ventricular function: a multicentre propensity-matched analysis
Schlotter F,
Miura M,
Kresoja K,
Alushi B,
Alessandrini H,
Attinger-Toller A,
Besler C,
Biasco L,
Braun D,
Brochet E,
Connelly K,
de Bruijn S,
Denti P,
Estévez-Loureiro R,
Fam N,
Gavazzoni M,
Himbert D,
Ho E,
Juliard J,
Kalbacher D,
Kaple R,
Kreidel F,
Latib A,
Lubos E,
Ludwig S,
Mehr M,
Monivas V,
Nazif T,
Nickenig G,
Pedrazzini G,
Pozzoli A,
Praz F,
Puri R,
Rodés-Cabau J,
Rommel K,
Schäfer U,
Schofer J,
Sievert H,
Tang G,
Thiele H,
Unterhuber M,
Vahanian A,
von Bardeleben R,
von Roeder M,
Webb J,
Weber M,
Wild M,
Windecker S,
Zuber M,
Hausleiter J,
Maisano F,
Leon M,
Hahn R,
Lauten A,
Taramasso M,
Lurz P
July 20, 2021 | 10.4244/EIJ-D-21-00191
Transcatheter tricuspid valve treatment: does annular reduction make a difference?
February 5, 2021 | 10.4244/EIJV16I15A219
Transcatheter treatment of multivalvular heart disease
November 20, 2020 | 10.4244/EIJ-D-20-00244
Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores
Ueki Y,
Bär S,
Losdat S,
Otsuka T,
Zanchin C,
Zanchin T,
Gragnano F,
Gargiulo G,
Siontis G,
Praz F,
Lanz J,
Hunziker L,
Stortecky S,
Pilgrim T,
Heg D,
Valgimigli M,
Windecker S,
Räber L
August 28, 2020 | 10.4244/EIJ-D-20-00052
Optimal fluoroscopic viewing angles of right-sided heart structures in patients with tricuspid regurgitation based on multislice computed tomography
Xiong T,
Pighi M,
Thériault-Lauzier P,
Leipsic J,
Spaziano M,
Martucci G,
Buithieu J,
Mousavi N,
Pilgrim T,
Praz F,
Windecker S,
Chen M,
Piazza N
November 15, 2019 | 10.4244/EIJ-D-19-00618
Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale
September 20, 2017 | 10.4244/EIJ-D-17-00061
Prognostic impact of invasive haemodynamic measurements in combination with clinical and echocardiographic characteristics on two-year clinical outcomes of patients undergoing transcatheter aortic valve implantation
Franzone A,
O’Sullivan C,
Stortecky S,
Heg D,
Lanz J,
Vollenbroich R,
Praz F,
Piccolo R,
Asami M,
Roost E,
Räber L,
Valgimigli M,
Windecker S,
Pilgrim T
April 7, 2017 | 10.4244/EIJ-D-16-00790
Bilateral, reversible coronary obstruction during aortic valve-in-valve implantation of a repositionable valve system
October 20, 2016 | 10.4244/EIJV12I9A194
A propensity score-matched comparison between Cardia and Amplatzer PFO closure devices - insights from the SOLUTION registry (Swiss percutaneOus patent foramen ovale cLosUre in recurrent clinical events prevenTION)
Puricel S,
Arroyo D,
Goy J-J,
Praz F,
Palhais N,
Wahl A,
Stauffer J-C,
Togni M,
Berger A,
Meier B,
Cook S
June 19, 2015 | 10.4244/EIJY14M05_05
Assessment of low-flow, low-gradient, severe aortic stenosis: an invasive evaluation is required for decision making
September 27, 2014 | 10.4244/EIJV10SUA9
Transcatheter mitral valve implantation (TMVI) using the Edwards FORTIS device
Bapat V,
Buellesfeld L,
Peterson M,
Hancock J,
Reineke D,
Buller C,
Carrel T,
Praz F,
Rajani R,
Fam N,
Kim H,
Redwood S,
Young C,
Munns C,
Windecker S,
Thomas M
September 27, 2014 | 10.4244/EIJV10SUA18
Cerebral protection devices for transcatheter aortic valve implantation: is better the enemy of good?
September 15, 2013 | 10.4244/EIJV9SSA26
Latest news
AHEAD OF PRINT
LVOT calcification in TAVI : a post hoc analysis from the SOLVE-TAVI trial
FREE ARTICLE - Serdar Farhan et al
August 9, 2022
NEW ISSUE
The 16th EBC Expert consensus; ticagrelor or aspirin monotherapy 1 year after PCI; vasospasm and atherosclerosis in ANOCA; lifetime valve journey; and more…
August 5, 2022
AHEAD OF PRINT
RADIANCE-HTN SOLO 36-month analysis
FREE ARTICLE - Florian Rader et al
August 1, 2022
AHEAD OF PRINT
Percutaneous left atrial appendage closure with superior vascular access
FREE ARTICLE - Roberto Galea et al
August 4, 2022
AHEAD OF PRINT
Dual ProGlide vs ProGlide and FemoSeal after TAVI
FREE ARTICLE - Jonas M.D. Gmeiner et al
July 29, 2022
AHEAD OF PRINT
Stent thrombosis in comatose OHCA (ST-OHCA Study)
FREE ARTICLE - Martin Rauber et al
July 25, 2022
AHEAD OF PRINT
Evolocumab and periprocedural microvascular damage
FREE ARTICLE - Masaharu Ishihara et al
July 15, 2022